Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Design Therapeutics, Inc. | 15,000 | reported | 31 May 2023 | tx 12+4,775,830−8,285,834 |
| NextCure, Inc. | 14,250 | reported | 24 Jun 2021 | tx 6+1,154,070−7,861,636 |
| Tempest Therapeutics, Inc. | 6,635 | reported | 01 Jul 2021 | tx 3+592,980 |
| ARMO BioSciences, Inc. | 0 | reported | 22 Jun 2018 | tx 5+422,900−827,800 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 31 May 2023 | GRANT_AWARD | Design Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 15 Jun 2022 | GRANT_AWARD | Design Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 22 Mar 2022 | SALE | Design Therapeutics, Inc. | 1,455 | 18.63 USD | |
| 18 Mar 2022 | SALE | Design Therapeutics, Inc. | 13,200 | 20.34 USD | |
| 18 Mar 2022 | SALE | Design Therapeutics, Inc. | 552,225 | 19.04 USD | |
| 21 Mar 2022 | SALE | Design Therapeutics, Inc. | 24,000 | 19.01 USD | |
| 01 Jul 2021 | GRANT_AWARD | Tempest Therapeutics, Inc. | 6,635 | — | deriv |
| 25 Jun 2021 | GRANT_AWARD | Tempest Therapeutics, Inc. | 579,710 | — | |
| 24 Jun 2021 | GRANT_AWARD | NextCure, Inc. | 14,250 | 0.00 USD | deriv |
| 30 Mar 2021 | CONVERSION | Design Therapeutics, Inc. | 4,439,839 | — | |
| 30 Mar 2021 | PURCHASE | Design Therapeutics, Inc. | 10,000 | 20.00 USD | first after silence |
| 30 Mar 2021 | CONVERSION | Design Therapeutics, Inc. | 280,991 | — | |
| 30 Mar 2021 | CONVERSION | Design Therapeutics, Inc. | 458,016 | 0.00 USD | deriv |
| 30 Mar 2021 | CONVERSION | Design Therapeutics, Inc. | 7,236,938 | 0.00 USD | deriv |
| 25 Mar 2021 | GRANT_AWARD | Design Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 11 Jun 2020 | GRANT_AWARD | NextCure, Inc. | 14,250 | 0.00 USD | deriv |
| 13 Jun 2019 | GRANT_AWARD | NextCure, Inc. | 22,000 | 0.00 USD | deriv |
| 13 May 2019 | CONVERSION | NextCure, Inc. | 978,570 | — | |
| 13 May 2019 | PURCHASE | NextCure, Inc. | 125,000 | 15.00 USD | |
| 13 May 2019 | CONVERSION | NextCure, Inc. | 7,861,636 | — | deriv |
| 22 Jun 2018 | TENDER | ARMO BioSciences, Inc. | 404,900 | 50.00 USD | |
| 22 Jun 2018 | OTHER | ARMO BioSciences, Inc. | 18,000 | 10.03 USD | deriv |
| 26 Mar 2018 | GRANT_AWARD | ARMO BioSciences, Inc. | 18,000 | 0.00 USD | deriv |
| 30 Jan 2018 | CONVERSION | ARMO BioSciences, Inc. | 404,900 | — | |
| 30 Jan 2018 | CONVERSION | ARMO BioSciences, Inc. | 404,900 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 30 Mar 2021.